BOOKS:
NUTRIENT POWER, HEAL YOUR BIOCHEMISTRY, HEAL YOUR BRAIN BY WILLIAM J. WALSH PhD
https://www.walshinstitute.org/the-book.html
https://www.walshinstitute.org/the-book.html
|
Several times in my report (Some of the Physical Causes of Depression, Bipolar Disorder, Schizophrenia & Other Mood, Brain & Physical Diseases) I quote Dr. William J. Walsh, his book and his scientific research: William J. Walsh, Ph.D., FACN, president of the non-profit Walsh Research Institute, is an internationally recognized expert in the field of nutritional medicine and a key scientist paving the way for nutrient-based psychiatry and nutritional medicine. Over the past 30 years, Dr. Walsh has developed biochemical treatments for patients diagnosed with behavioral disorders, attention deficit (hyperactivity) disorder, autism, clinical depression, anxiety, bipolar disorders, schizophrenia, and Alzheimer’s disease that are used by doctors throughout the world. His book, Nutrient Power: Heal Your Biochemistry and Heal Your Brain [updated May 2014], describes specific findings for his evidence-based nutrient therapy system. Dr. Walsh has studied more than 30,000 patients with mental disorders acquiring an unparalleled database of more than 3 million chemical assays during his clinical and research work. https://www.walshinstitute.org/
- Professional help: A listing of doctors and clinics that provide biochemical/nutrient therapy in or near your state or country (and telemedicine practitioner’s available through skype/phone appointments) is provided on the Walsh Institute website: https://www.walshinstitute.org/clinical-resources.html
- Laboratory testing: https://www.dhalab.com
The following are some books that come from a movement that’s been shouting for decades:
WAKE UP and stop letting psychiatric systems cause harm
Books Exposing Psychiatric Drugs and Modern Psychiatry
(Organized by Author, Theme, with Publication Years)
Robert Whitaker (Publisher of www.madinamerica.com)
Robert Whitaker is a medical journalist whose books examine psychiatric drug outcomes, long-term trends in disability, and institutional influences on psychiatry.
Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill (2002)
Examines the history of psychiatric treatment in the U.S. and argues that biological psychiatry’s drug-centered approaches have often produced worse long-term outcomes than harm avoided, questioning the scientific basis of conventional treatments.
Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America (2010)
Investigates why rates of disability for mental illness have risen even as psychiatric drugs have become more widely used, critiquing assumptions about long-term efficacy and offering data-driven challenges to conventional practice.
Psychiatry Under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform (2015, with Lisa Cosgrove)
Explores the role of pharmaceutical industry conflicts of interest and institutional influences in shaping diagnostic criteria, treatment guidelines, and public understanding of psychiatric drugs.
Peter R. Breggin, M.D.
Peter Breggin is a psychiatrist and prominent critic of psychopharmacology and the biological model of mental illness.
Toxic Psychiatry: Why Therapy, Empathy, and Love Must Replace the Drugs, Electroshock & Biochemical Theories of the “New Psychiatry” (1991)
Challenges the chemical imbalance model and argues for therapeutic, empathic, and non-drug treatments for emotional distress.
Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex (2008)
Argues that many psychiatric treatments suppress normal brain function rather than restore health, and critiques institutional reliance on drugs and electroshock.
Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide, and Crime (2008)
Presents case histories and research alleging psychiatric drugs can contribute to agitation, violence, suicidality, and loss of emotional control.
Your Drug May Be Your Problem: How and Why to Stop Taking Psychiatric Drugs (2008, with David Cohen)
Argues many psychiatric symptoms are drug-induced and provides guidance on gradual tapering and withdrawal challenges.
Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and Their Families (2013)
Focuses specifically on the challenges of discontinuing psychiatric drugs and best practices for safe withdrawal.
Talking Back to Prozac: What Doctors Aren’t Telling You About Today’s Most Controversial Drug (1994)
Critiques claims about Prozac’s safety and effectiveness and discusses emotional blunting, agitation, and side effects.
Antidepressant-Specific Books
Critical Analyses of SSRIs and Antidepressants
The Emperor’s New Drugs: Exploding the Antidepressant Myth — Irving Kirsch, Ph.D. (2010)
Analyzes antidepressant clinical trial data and argues many antidepressants perform only marginally better than placebo, challenging standard efficacy claims.
Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil, and Other Antidepressants with Safe, Effective Alternatives — Joseph Glenmullen, M.D. (2000)
Documents adverse effects of common antidepressants and explores alternative approaches to treatment.
Side Effects: A Prosecutor, a Whistleblower, and a Bestselling Antidepressant on Trial — Alison Bass (2008)
Investigates legal cases and controversies around antidepressant marketing, data suppression, and consumer risk.
Talking Back to Prozac: What Doctors Aren’t Telling You About Today’s Most Controversial Drug — Peter R. Breggin, M.D. (1994)
Critiques Prozac’s widespread use, safety claims, and non-disclosure of potential behavioral side effects.
Antipsychotic & Big Pharma Critiques
Zyprexa & Antipsychotic Industry Exposure
The Zyprexa Papers: Big Pharma Meets Big Diagnosis, Big Courts, and Big Psychiatric Hospitals — Jim Gottstein (2021)
Documents legal battles and leaked internal documents revealing alleged concealment of harm and illegal promotion of the antipsychotic Zyprexa, connecting pharmaceutical industry practices with patient risk and systemic problems.
Broader Pharmaceutical & Industry Critiques
Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare — Peter C. Gøtzsche, M.D. (2013)
Argues that pharmaceutical companies manipulate research, regulatory systems, and marketing, leading to widespread harm across medical practice.
Anti-Psychiatry & Diagnostic System Critiques
The Myth of Mental Illness: Foundations of a Theory of Personal Conduct — Thomas Szasz, M.D. (1961)
Challenges the medicalized concept of mental illness and critiques psychiatric authority and coercive treatment.
The Book of Woe: The DSM and the Unmaking of Psychiatry — Gary Greenberg (2013)
Examines how psychiatric diagnoses are culturally constructed and politically influenced rather than strictly scientific.
Unhinged: The Trouble with Psychiatry — A Doctor’s Revelations About a Profession in Crisis — Daniel J. Carlat, M.D. (2010)
An insider critique of psychiatric practice, medication reliance, and industry influence.
The Protest Psychosis: How Schizophrenia Became a Black Disease — Jonathan Metzl (2010)
Analyzes historical bias in psychiatric diagnosis tied to race and institutional power.
Withdrawal, Lived Experience & Consumer Perspectives
Coming Off Psychiatric Drugs — Peter Lehmann (ed.) (2004)
A collection of international perspectives on psychiatric drug withdrawal experiences and challenges.
Psychiatric Drugs: Key Issues and Service User Perspectives — Jim Read (2009)
Explores lived experiences of people who have used and attempted to discontinue psychiatric drugs.
Forced Treatment & Civil Rights
And They Call It Help: The Psychiatric Policing of America’s Children — Louise Armstrong (1997)
Documents cases of involuntary psychiatric treatment and drugging of children.
Tranquil Prisons: Chemical Incarceration Under Community Treatment Orders — Erick Fabris (2014)
Examines legal mandates for psychiatric drug compliance and civil liberties issues related to forced treatment.
(Organized by Author, Theme, with Publication Years)
Robert Whitaker (Publisher of www.madinamerica.com)
Robert Whitaker is a medical journalist whose books examine psychiatric drug outcomes, long-term trends in disability, and institutional influences on psychiatry.
Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill (2002)
Examines the history of psychiatric treatment in the U.S. and argues that biological psychiatry’s drug-centered approaches have often produced worse long-term outcomes than harm avoided, questioning the scientific basis of conventional treatments.
Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America (2010)
Investigates why rates of disability for mental illness have risen even as psychiatric drugs have become more widely used, critiquing assumptions about long-term efficacy and offering data-driven challenges to conventional practice.
Psychiatry Under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform (2015, with Lisa Cosgrove)
Explores the role of pharmaceutical industry conflicts of interest and institutional influences in shaping diagnostic criteria, treatment guidelines, and public understanding of psychiatric drugs.
Peter R. Breggin, M.D.
Peter Breggin is a psychiatrist and prominent critic of psychopharmacology and the biological model of mental illness.
Toxic Psychiatry: Why Therapy, Empathy, and Love Must Replace the Drugs, Electroshock & Biochemical Theories of the “New Psychiatry” (1991)
Challenges the chemical imbalance model and argues for therapeutic, empathic, and non-drug treatments for emotional distress.
Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex (2008)
Argues that many psychiatric treatments suppress normal brain function rather than restore health, and critiques institutional reliance on drugs and electroshock.
Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide, and Crime (2008)
Presents case histories and research alleging psychiatric drugs can contribute to agitation, violence, suicidality, and loss of emotional control.
Your Drug May Be Your Problem: How and Why to Stop Taking Psychiatric Drugs (2008, with David Cohen)
Argues many psychiatric symptoms are drug-induced and provides guidance on gradual tapering and withdrawal challenges.
Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists, Patients and Their Families (2013)
Focuses specifically on the challenges of discontinuing psychiatric drugs and best practices for safe withdrawal.
Talking Back to Prozac: What Doctors Aren’t Telling You About Today’s Most Controversial Drug (1994)
Critiques claims about Prozac’s safety and effectiveness and discusses emotional blunting, agitation, and side effects.
Antidepressant-Specific Books
Critical Analyses of SSRIs and Antidepressants
The Emperor’s New Drugs: Exploding the Antidepressant Myth — Irving Kirsch, Ph.D. (2010)
Analyzes antidepressant clinical trial data and argues many antidepressants perform only marginally better than placebo, challenging standard efficacy claims.
Prozac Backlash: Overcoming the Dangers of Prozac, Zoloft, Paxil, and Other Antidepressants with Safe, Effective Alternatives — Joseph Glenmullen, M.D. (2000)
Documents adverse effects of common antidepressants and explores alternative approaches to treatment.
Side Effects: A Prosecutor, a Whistleblower, and a Bestselling Antidepressant on Trial — Alison Bass (2008)
Investigates legal cases and controversies around antidepressant marketing, data suppression, and consumer risk.
Talking Back to Prozac: What Doctors Aren’t Telling You About Today’s Most Controversial Drug — Peter R. Breggin, M.D. (1994)
Critiques Prozac’s widespread use, safety claims, and non-disclosure of potential behavioral side effects.
Antipsychotic & Big Pharma Critiques
Zyprexa & Antipsychotic Industry Exposure
The Zyprexa Papers: Big Pharma Meets Big Diagnosis, Big Courts, and Big Psychiatric Hospitals — Jim Gottstein (2021)
Documents legal battles and leaked internal documents revealing alleged concealment of harm and illegal promotion of the antipsychotic Zyprexa, connecting pharmaceutical industry practices with patient risk and systemic problems.
Broader Pharmaceutical & Industry Critiques
Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare — Peter C. Gøtzsche, M.D. (2013)
Argues that pharmaceutical companies manipulate research, regulatory systems, and marketing, leading to widespread harm across medical practice.
Anti-Psychiatry & Diagnostic System Critiques
The Myth of Mental Illness: Foundations of a Theory of Personal Conduct — Thomas Szasz, M.D. (1961)
Challenges the medicalized concept of mental illness and critiques psychiatric authority and coercive treatment.
The Book of Woe: The DSM and the Unmaking of Psychiatry — Gary Greenberg (2013)
Examines how psychiatric diagnoses are culturally constructed and politically influenced rather than strictly scientific.
Unhinged: The Trouble with Psychiatry — A Doctor’s Revelations About a Profession in Crisis — Daniel J. Carlat, M.D. (2010)
An insider critique of psychiatric practice, medication reliance, and industry influence.
The Protest Psychosis: How Schizophrenia Became a Black Disease — Jonathan Metzl (2010)
Analyzes historical bias in psychiatric diagnosis tied to race and institutional power.
Withdrawal, Lived Experience & Consumer Perspectives
Coming Off Psychiatric Drugs — Peter Lehmann (ed.) (2004)
A collection of international perspectives on psychiatric drug withdrawal experiences and challenges.
Psychiatric Drugs: Key Issues and Service User Perspectives — Jim Read (2009)
Explores lived experiences of people who have used and attempted to discontinue psychiatric drugs.
Forced Treatment & Civil Rights
And They Call It Help: The Psychiatric Policing of America’s Children — Louise Armstrong (1997)
Documents cases of involuntary psychiatric treatment and drugging of children.
Tranquil Prisons: Chemical Incarceration Under Community Treatment Orders — Erick Fabris (2014)
Examines legal mandates for psychiatric drug compliance and civil liberties issues related to forced treatment.